177 related articles for article (PubMed ID: 30810582)
1. Aptamer-guided acridine derivatives for cervical cancer.
Carvalho J; Lopes-Nunes J; Lopes AC; Cabral Campello MP; Paulo A; Queiroz JA; Cruz C
Org Biomol Chem; 2019 Mar; 17(11):2992-3002. PubMed ID: 30810582
[TBL] [Abstract][Full Text] [Related]
2. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Aptamer as a Potential Drug Targeted Delivery for Retinal Angiogenesis Inhibition.
Moreira D; Lopes-Nunes J; Santos FM; Campello MPC; Oliveira MC; Paulo A; Tomaz C; Cruz C
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242534
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of a DNA aptamer by ligand binding.
Santos T; Lopes-Nunes J; Alexandre D; Miranda A; Figueiredo J; Silva MS; Mergny JL; Cruz C
Biochimie; 2022 Sep; 200():8-18. PubMed ID: 35550917
[TBL] [Abstract][Full Text] [Related]
5. Phthalocyanines for G-quadruplex aptamers binding.
Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
[TBL] [Abstract][Full Text] [Related]
6. G-Quadruplex Aptamer-Ligand Characterization.
Moreira D; Leitão D; Lopes-Nunes J; Santos T; Figueiredo J; Miranda A; Alexandre D; Tomaz C; Mergny JL; Cruz C
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296374
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
8. RNA G-quadruplex as supramolecular carrier for cancer-selective delivery.
Santos T; Pereira P; Campello MPC; Paulo A; Queiroz JA; Cabrita E; Cruz C
Eur J Pharm Biopharm; 2019 Sep; 142():473-479. PubMed ID: 31325486
[TBL] [Abstract][Full Text] [Related]
9. Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma.
Lopes-Nunes J; Lifante J; Shen Y; Ximendes EC; Jaque D; Iglesias-de la Cruz MC; Cruz C
Eur J Pharm Biopharm; 2020 Sep; 154():228-235. PubMed ID: 32707287
[TBL] [Abstract][Full Text] [Related]
10. G-quadruplex structure of an anti-proliferative DNA sequence.
Do NQ; Chung WJ; Truong THA; Heddi B; Phan AT
Nucleic Acids Res; 2017 Jul; 45(12):7487-7493. PubMed ID: 28549181
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent light-up acridine orange derivatives bind and stabilize KRAS-22RT G-quadruplex.
Carvalho J; Pereira E; Marquevielle J; Campello MPC; Mergny JL; Paulo A; Salgado GF; Queiroz JA; Cruz C
Biochimie; 2018 Jan; 144():144-152. PubMed ID: 29129745
[TBL] [Abstract][Full Text] [Related]
12. Gallic Acid-Triethylene Glycol Aptadendrimers Synthesis, Biophysical Characterization and Cellular Evaluation.
Miranda A; Lopez-Blanco R; Lopes-Nunes J; Melo AM; Campello MPC; Paulo A; Oliveira MC; Mergny JL; Oliveira PA; Fernandez-Megia E; Cruz C
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432647
[TBL] [Abstract][Full Text] [Related]
13. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of fluorescent G-quadruplex DNA binding ligands for the comparison of terminal group effects in molecular interaction: Phenol versus methoxybenzene.
Jin J; Hou J; Long W; Zhang X; Lu YJ; Li D; Zhang K; Wong WL
Bioorg Chem; 2020 Jun; 99():103821. PubMed ID: 32279036
[TBL] [Abstract][Full Text] [Related]
15. Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro.
Carvalho J; Lopes-Nunes J; Vialet B; Rosado T; Gallardo E; Vale J; Eloy C; Ferreira S; Palmeira-de-Oliveira R; Campello MPC; Paulo A; Barthélémy P; Mergny JL; Salgado GF; Queiroz JA; Ellington AD; Cruz C
Nanomedicine; 2021 Aug; 36():102429. PubMed ID: 34174419
[TBL] [Abstract][Full Text] [Related]
16. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
17. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
[TBL] [Abstract][Full Text] [Related]
18. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells.
Ogloblina AM; Khristich AN; Karpechenko NY; Semina SE; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Biochimie; 2018 Feb; 145():163-173. PubMed ID: 29208488
[TBL] [Abstract][Full Text] [Related]
19. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity of 2,7-diamino l0-(3,5-dimethoxy)benzyl-9(10H)-acridone derivatives as potent telomeric G-quadruplex DNA ligands.
Gao C; Zhang W; He S; Li S; Liu F; Jiang Y
Bioorg Chem; 2015 Jun; 60():30-6. PubMed ID: 25912692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
